Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION

NCT07388030 is registered in ClinicalTrials.gov with Shanghai Bluesail Boyuan Medical Technology Co., Ltd. as lead sponsor.

NCT NCT07388030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07388030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION
Lead sponsor
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 20, 2026
Completion date
June 30, 2030
Enrollment
3,060 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery calcification, coronary artery disease, severe coronary artery disease